Publications 2025

Bisogno G, Chisholm J, Hladun R, De Salvo GL, Guerin F, Casanova M, Mandeville H, Alaggio R, Coppadoro B, Orbach D, Ferrari A, van Rijn R, Defachelles AS, Ben-Arush M, Glosli H, Cesen M, Merks JHM, Minard-Colin V (2025)
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial
J Clin Oncol, JCO2402850 (in press)
DOI 10.1200/JCO-24-02850, PubMed 40053891

de Kovel M, van Haaster AC, Carcao M, Ranta S, Glosli H, Rivard GE, Kenet G, Kurnik K, Van Geet C, Carvalho M, Andersson NG, Kartal-Kaess M, Ljung R, van den Berg HM, PedNet Study Group (2025)
Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group
Haemophilia (in press)
DOI 10.1111/hae.70035, PubMed 40123267

Klamroth R, Al Saleh M, Glosli H, Schiavulli M, Guillet B, Bystrická L, Schönstein A, Lethagen S (2025)
Immune Tolerance Induction With a Recombinant Factor VIII Fc in Haemophilia A: Data From a Chart Review Study
Eur J Haematol (in press)
DOI 10.1111/ejh.14427, PubMed 40289300

Mandeville HC, Bisogno G, Minard-Colin V, Alaggio R, Ben-Arush M, Chargari C, Coppadoro B, Craigie R, Devalck C, Ferman S, Ferrari A, Glosli H, Alvaro RH, Hol M, Mudry P, Orbach D, Albiac MR, Merks JHM, Jenney MEM (2025)
Reply to "Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma. How much is enough?"
Cancer, 131 (4), e35744
DOI 10.1002/cncr.35744, PubMed 39916392

Publications 2024

Ljung R, Chan AKC, Ahuja SP, Mancuso ME, Marquez JFC, Volk F, Blanchette V, Kerlin BA, Trakymiene SS, Glosli H, Kenet G (2024)
BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the LEOPOLD Kids Extension Study
Eur J Haematol, 114 (3), 556-565
DOI 10.1111/ejh.14362, PubMed 39667975

Mandeville HC, Bisogno G, Minard-Colin V, Alaggio R, Ben-Arush M, Chargari C, Coppadoro B, Craigie R, Devalck C, Ferman S, Ferrari A, Glosli H, Alvaro RH, Hol M, Mudry P, Orbach D, Albiac MR, Merks JHM, Jenney MEM (2024)
Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial
Cancer, 130 (23), 4071-4084
DOI 10.1002/cncr.35497, PubMed 39058728

Mårtensson A, Letelier A, Manderstedt E, Glosli H, Ljung R (2024)
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
Haemophilia, 30 (3), 774-779
DOI 10.1111/hae.15019, PubMed 38632836

van der Zwet K, de Kovel M, Motwani J, van Geet C, Nolan B, Glosli H, Escuriola Ettingshausen C, Königs C, Kenet G, Fischer K, PedNet Investigators (2024)
Bleeding control improves after switching to emicizumab: Real-world experience of 177 children in the PedNet registry
Haemophilia, 30 (3), 685-692
DOI 10.1111/hae.15015, PubMed 38578720

Publications 2023

Bisogno G, Minard-Colin V, Zanetti I, Ferrari A, Gallego S, Dávila Fajardo R, Mandeville H, Kelsey A, Alaggio R, Orbach D, Terwisscha van Scheltinga S, Guillén Burrieza G, Ben-Arush M, Glosli H, Mudry P, Ferman S, Devalck C, Defachelles AS, Merks JHM, Jenney M (2023)
Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study
J Clin Oncol, 41 (13), 2342-2349
DOI 10.1200/JCO.22.02093, PubMed 36848614

Ghetti CM, Gaden TS, Bieleninik L, Kvestad I, Assmus J, Stordal AS, Aristizabal Sanchez LF, Arnon S, Dulsrud J, Elefant C, Epstein S, Ettenberger M, Glosli H, Konieczna-Nowak L, Lichtensztejn M, Lindvall MW, Mangersnes J, Murcia Fernández LD, Røed CJ, Saá G, Van Roy B, Vederhus BJ, Gold C (2023)
Effect of Music Therapy on Parent-Infant Bonding Among Infants Born Preterm: A Randomized Clinical Trial
JAMA Netw Open, 6 (5), e2315750
DOI 10.1001/jamanetworkopen.2023.15750, PubMed 37234006

Ljung R, Chan AKC, Glosli H, Afonja O, Becker B, Tseneklidou-Stoeter D, Mancuso ME, Saulyte-Trakymiene S, Kenet G (2023)
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial
Thromb Haemost, 123 (1), 27-39
DOI 10.1055/s-0042-1757876, PubMed 36626898

Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
Haemophilia, 29 (2), 658-667
DOI 10.1111/hae.14752, PubMed 36723510

Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
Factors associated with physical activity in young people with haemophilia A on prophylaxis
Haemophilia, 29 (3), 900-909
DOI 10.1111/hae.14776, PubMed 36913380

van Ewijk R, Chatziantoniou C, Adams M, Bertolini P, Bisogno G, Bouhamama A, Caro-Dominguez P, Charon V, Coma A, Dandis R, Devalck C, De Donno G, Ferrari A, Fiocco M, Gallego S, Giraudo C, Glosli H, Ter Horst SAJ, Jenney M, Klein WM, Leemans A, Leseur J, Mandeville HC, McHugh K, Merks JHM et al. (2023)
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
Pediatr Radiol, 53 (12), 2539-2551
DOI 10.1007/s00247-023-05745-z, PubMed 37682330

Publications 2022

Chargari C, Haie-Meder C, Espenel S, Garcia MA, Ben-Arush M, Bolle S, Borjesson A, Cesen M, Lago RC, Defachelles AS, De Moerloose B, Devalck C, Edslev P, Farinha NJ, Francotte N, Glosli H, Gouy S, Burrieza GG, Helfre S, Irtan S, Kattamis A, Lacerda A, Levy A, Hjalgrim LL, Mansuy L et al. (2022)
Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments
Int J Radiat Oncol Biol Phys, 113 (3), 602-613
DOI 10.1016/j.ijrobp.2022.03.003, PubMed 35278672

Ferrari A, Chisholm JC, Jenney M, Minard-Colin V, Orbach D, Casanova M, Guillen G, Glosli H, van Rijn RR, Schoot RA, Cameron AL, Rogers T, Alaggio R, Ben-Arush M, Mandeville HC, Devalck C, Defachelles AS, Coppadoro B, Bisogno G, Merks JHM (2022)
Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study
Lancet Child Adolesc Health, 6 (8), 545-554
DOI 10.1016/S2352-4642(22)00121-3, PubMed 35690071

Matlary RED, Holme PA, Glosli H, Rueegg CS, Grydeland M (2022)
Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia
Haemophilia, 28 (6), e172-e180
DOI 10.1111/hae.14624, PubMed 35830613

Mercolini F, Merks JHM, Minard-Colin V, Cameron A, van Scheltinga SEJT, Sher O, Fichera G, Orbach D, Glosli H, Coppadoro B, Gallego S, Chisholm JC, Bisogno G (2022)
Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report
Pediatr Blood Cancer, 70 (3), e30143
DOI 10.1002/pbc.30143, PubMed 36519598

Rogers T, Zanetti I, Coppadoro B, Martelli H, Jenney M, Minard-Colin V, Terwisscha van Scheltinga SEJ, Skerritt C, Fajardo RD, Guérin F, Kelsey A, Merks JHM, Mandeville H, Guillén G, Glosli H, De Corti F, Bisogno G (2022)
Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies
Pediatr Blood Cancer, 69 (9), e29739
DOI 10.1002/pbc.29739, PubMed 35460336

Publications 2021

Andersen E, Chollet ME, Sletten M, Stavik B, Skarpen E, Backe PH, Thiede B, Glosli H, Henriksson CE, Iversen N (2021)
Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding
Thromb Haemost, 121 (12), 1588-1598
DOI 10.1055/a-1450-8568, PubMed 33742435

Bergeron C, Jenney M, De Corti F, Gallego S, Merks H, Glosli H, Ferrari A, Ranchère-Vince D, De Salvo GL, Zanetti I, Chisholm J, Minard-Colin V, Rogers T, Bisogno G, European paediatric Soft tissue sarcoma Study Group (EpSSG) (2021)
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience
Eur J Cancer, 146, 21-29
DOI 10.1016/j.ejca.2020.12.025, PubMed 33567392

Glosli H, Bisogno G, Kelsey A, Chisholm JC, Gaze M, Kolb F, McHugh K, Shipley J, Gallego S, Merks JHM, Smeele LE, Mandeville H, Ferrari A, Minard-Colin V, Corradini N, Jenney M, Zanetti I, De Salvo GL, Orbach D, EpSSG members (2021)
Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study
Eur J Cancer, 151, 84-93
DOI 10.1016/j.ejca.2021.04.007, PubMed 33971448

Lepola P, Kindred M, Giannuzzi V, Glosli H, Dehlinger-Kremer M, Dalrymple H, Neubauer D, Boylan GB, Conway J, Dewhurst J, Hoffman D (2021)
Informed consent and assent guide for paediatric clinical trials in Europe
Arch Dis Child, 107 (6), 582-590
DOI 10.1136/archdischild-2021-322798, PubMed 34853000

Schultz NH, Glosli H, Bjørnsen S, Holme PA (2021)
The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study
Res Pract Thromb Haemost, 5 (5), e12561
DOI 10.1002/rth2.12561, PubMed 34263107

Slater O, Gains JE, Kelsey AM, De Corti F, Zanetti I, Coppadoro B, Jorgensen M, Gallego S, Orbach DH, Glosli H, Cesen M, Gaze MN, Smeulders N, Ferrari A, Jenney M, Minard-Colin V, Bisogno G, Merks JHM, European paediatric Soft tissue sarcoma Study Group (2021)
Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study
Eur J Cancer, 160, 206-214
DOI 10.1016/j.ejca.2021.10.031, PubMed 34865946

Publications 2020

Skjefstad K, Solberg O, Glosli H, von der Lippe C, Feragen KB (2020)
Life expectancy and cause of death in individuals with haemophilia A and B in Norway, 1986-2018
Eur J Haematol, 105 (5), 608-615
DOI 10.1111/ejh.13494, PubMed 32710483

Terwisscha van Scheltinga SEJ, Wijnen MHWA, Martelli H, Rogers T, Mandeville H, Gaze MN, McHugh K, Corradini N, Orbach D, Jenney M, Kelsey A, Chisholm J, Gallego S, Glosli H, Ferrari A, Zanetti I, De Salvo GL, Minard-Colin V, Bisogno G, van Noesel MM, Merks HHM (2020)
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study
Cancer Med, 9 (20), 7580-7589
DOI 10.1002/cam4.3365, PubMed 32869534

Publications 2019

Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, Martelli H, Minard-Colin V, Orbach D, Glosli H, Chisholm J, Casanova M, Zanetti I, Devalck C, Ben-Arush M, Mudry P, Ferman S, Jenney M, Ferrari A, European paediatric Soft tissue sarcoma Study Group (2019)
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Lancet Oncol, 20 (11), 1566-1575
DOI 10.1016/S1470-2045(19)30617-5, PubMed 31562043

Naumburg E, Rane A, Halvorsen T, Glosli H, Henriksen TB, Haraldsson À, Kallio J, Lepola P (2019)
Tardy development of safe medicines for children: a Nordic network offers new platform to reduce this inequity
Acta Paediatr, 108 (6), 992-993
DOI 10.1111/apa.14775, PubMed 30844088

Skou AS, Olsen SØ, Nielsen LH, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2019)
Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study
J Pediatr Hematol Oncol, 41 (1), e12-e17
DOI 10.1097/MPH.0000000000001302, PubMed 30550508

Publications 2018

Bisogno G, Jenney M, Bergeron C, Gallego Melcón S, Ferrari A, Oberlin O, Carli M, Stevens M, Kelsey A, De Paoli A, Gaze MN, Martelli H, Devalck C, Merks JH, Ben-Arush M, Glosli H, Chisholm J, Orbach D, Minard-Colin V, De Salvo GL, European paediatric Soft tissue sarcoma Study Group (2018)
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Lancet Oncol, 19 (8), 1061-1071
DOI 10.1016/S1470-2045(18)30337-1, PubMed 29941280

Gallego S, Zanetti I, Orbach D, Ranchère D, Shipley J, Zin A, Bergeron C, de Salvo GL, Chisholm J, Ferrari A, Jenney M, Mandeville HC, Rogers T, Merks JHM, Mudry P, Glosli H, Milano GM, Ferman S, Bisogno G, European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (2018)
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Cancer, 124 (15), 3201-3209
DOI 10.1002/cncr.31553, PubMed 29797665

Wilhelmsson M, Glosli H, Ifversen M, Abrahamsson J, Winiarski J, Jahnukainen K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2018)
Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study
Bone Marrow Transplant, 54 (5), 726-736
DOI 10.1038/s41409-018-0337-8, PubMed 30242226

Publications 2017

Vaarwerk B, van der Lee JH, Breunis WB, Orbach D, Chisholm JC, Cozic N, Jenney M, van Rijn RR, McHugh K, Gallego S, Glosli H, Devalck C, Gaze MN, Kelsey A, Bergeron C, Stevens MCG, Oberlin O, Minard-Colin V, Merks JHM (2017)
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study
Cancer, 124 (5), 1016-1024
DOI 10.1002/cncr.31157, PubMed 29211298

Zeller B, Glosli H, Forestier E, Ha SY, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Hasle H, Abrahamsson J, NOPHO AML working group (2017)
Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10⁹ /l. The NOPHO experience 1984-2014
Br J Haematol, 178 (3), 448-456
DOI 10.1111/bjh.14692, PubMed 28542715

Publications 2016

Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D, Chisholm JC, Gallego S, Glosli H, De Salvo GL, Botta L, Gatta G, Bisogno G, RARECAREnet Working Group (2016)
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
Pediatr Blood Cancer, 64 (6)
DOI 10.1002/pbc.26348, PubMed 27882658

Publications 2015

Jarfelt M, Andersen NH, Glosli H, Jahnukainen K, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2015)
Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Eur J Haematol, 97 (1), 55-62
DOI 10.1111/ejh.12683, PubMed 26383901

Publications 2014

Skou AS, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2014)
Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study
Pediatr Blood Cancer, 61 (9), 1638-43
DOI 10.1002/pbc.25069, PubMed 24760750

Publications 2013

Molgaard-Hansen L, Skou AS, Juul A, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2013)
Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 60 (12), 1988-95
DOI 10.1002/pbc.24715, PubMed 24038890

Publications 2011

Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2011)
Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia
Br J Haematol, 152 (5), 623-30
DOI 10.1111/j.1365-2141.2010.08554.x, PubMed 21241281

Publications 2010

Molgaard-Hansen L, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2010)
Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 57 (7), 1222-9
DOI 10.1002/pbc.22931, PubMed 22095929

Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2010)
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003
Br J Haematol, 151 (5), 447-59
DOI 10.1111/j.1365-2141.2010.08389.x, PubMed 20955398

Publications 2008

Glosli H, Stray-Pedersen A, Brun AC, Holtmon LW, Tønjum T, Chapgier A, Casanova JL, Abrahamsen TG (2008)
Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-gamma receptor deficiency
Clin Infect Dis, 46 (3), e23-7
DOI 10.1086/525855, PubMed 18171304

Publications 2005

Glosli H, Gudbrandsen OA, Mullen AJ, Halvorsen B, Røst TH, Wergedahl H, Prydz H, Aukrust P, Berge RK (2005)
Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha
Biochim Biophys Acta, 1734 (3), 235-46
DOI 10.1016/j.bbalip.2005.02.011, PubMed 15893958

Publications 2004

Glosli H, Prydz H, Roald B (2004)
Involution of thymus and lymphoid depletion in mice expressing the hTNF transgene
APMIS, 112 (1), 63-73
DOI 10.1111/j.1600-0463.2004.apm1120111.x, PubMed 14961977

Publications 2003

Glosli H (2003)
Pleiotropic effects of low, persistent expression of human TNF in transgenic mice
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 138, 1 b. (flere pag.)
BIBSYS 032121024, ISBN 82-8072-096-0

Publications 2002

Glosli H, Tronstad KJ, Wergedal H, Müller F, Svardal A, Aukrust P, Berge RK, Prydz H (2002)
Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
FASEB J, 16 (11), 1450-2
DOI 10.1096/fj.01-0948fje, PubMed 12205044

Publications 1999

Glosli H, Veiby OP, Fjerdingstad H, Mehlum A, Probert L, Kollias G, Gjernes E, Prydz H (1999)
Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice
Eur J Haematol, 63 (1), 50-60
DOI 10.1111/j.1600-0609.1999.tb01850.x, PubMed 10414455

Publications 1992

Dahl-Jørgensen K, Glosli H, Joner G, Rønningen KS, Søvik O (1992)
[Can type 1 diabetes be prevented?]
Tidsskr Nor Laegeforen, 112 (23), 2951-2
PubMed 1412340